Sagimet Biosciences (NASDAQ: SGMT) Progresses Denifanstat in Key Phase 3 Acne Trial
| Show full article |
|
This functionality is available for registred users only
|
-
Full nameCitigroup Inc
-
Registration countryUSA
-
IndustryBanks
-
М/S&P/F
*** /*** /***









